Cargando…

Genetic analyses of differences between solid and nonsolid predominant lung adenocarcinomas

BACKGROUND: Solid predominant lung adenocarcinomas (LUAD) have distinct histopathological and clinical characteristics compared with nonsolid subtypes. A comprehensive comparison of altered genes found in solid and nonsolid subtypes has not previously been performed. In this study, we analyzed diffe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Jizhuang, Ma, Ke, Shi, Yu, Chen, Zongwei, Zhao, Mengnan, Huang, Yiwei, Wang, Shuai, Xi, Junjie, Zhan, Cheng, Xu, Songtao, Wang, Qun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275839/ https://www.ncbi.nlm.nih.gov/pubmed/30276966 http://dx.doi.org/10.1111/1759-7714.12876

Ejemplares similares

Coordination of Caregiver Naming and Children’s Exploration of Solid Objects and Nonsolid Substances
por: Perry, Lynn K., et al.
Publicado: (2022)

Adenocarcinoma with BAC Features Presented as the Nonsolid Nodule Is Prone to Be False-Negative on (18)F-FDG PET/CT
por: Wu, Hu-bing, et al.
Publicado: (2015)

Small-sized Pulmonary Adenocarcinoma Manifesting Skip-like Transition from Nonsolid Nodule: A Case Report
por: Hanaoka, Takaomi, et al.
Publicado: (2022)

Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma
por: Chen, Zhencong, et al.
Publicado: (2019)

Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma
por: Luo, Jizhuang, et al.
Publicado: (2016)

Solid component ratio influences prognosis of GGO-featured IA stage invasive lung adenocarcinoma
por: Sun, Fenghao, et al.
Publicado: (2020)

UV-C Light: A Promising Preservation Technology for Vegetable-Based Nonsolid Food Products
por: Tchonkouang, Rose Daphnee, et al.
Publicado: (2023)

Landscape and dynamics of single tumor and immune cells in early and advanced‐stage lung adenocarcinoma
por: Chen, Zhencong, et al.
Publicado: (2021)

Single-cell transcriptome atlas of lung adenocarcinoma featured with ground glass nodules
por: Lu, Tao, et al.
Publicado: (2020)

Value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non‐predominant lung adenocarcinoma
por: Cao, Shuhui, et al.
Publicado: (2018)

Software-based quantitative CT analysis to predict the growth trend of persistent nonsolid pulmonary nodules: a retrospective study
por: Borghesi, Andrea, et al.
Publicado: (2023)

The clinical prognostic factors of patients with stage IB lung adenocarcinoma
por: Sui, Qihai, et al.
Publicado: (2021)

Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma
por: Zhang, Zhenfa, et al.
Publicado: (2013)

Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma
por: Hu, Zhengyang, et al.
Publicado: (2023)

Knockdown of SMAD3 inhibits the growth and enhances the radiosensitivity of lung adenocarcinoma via p21 in vitro and in vivo
por: Niu, Hao, et al.
Publicado: (2020)

Assessment of the prognostic factors in patients with pulmonary carcinoid tumor: a population‐based study
por: Huang, Yiwei, et al.
Publicado: (2018)

Survival and Long-Term Cause-Specific Mortality Associated With Stage IA Lung Adenocarcinoma After Wedge Resection vs. Segmentectomy: A Population-Based Propensity Score Matching and Competing Risk Analysis
por: Zhao, Mengnan, et al.
Publicado: (2019)

Multi-omics analysis unravels the underlying mechanisms of poor prognosis and differential therapeutic responses of solid predominant lung adenocarcinoma
por: Li, Feng, et al.
Publicado: (2023)

Genetic and microenvironmental differences in non-smoking lung adenocarcinoma patients compared with smoking patients
por: Sui, Qihai, et al.
Publicado: (2020)

Development and validation of a nomogram for predicting the overall survival of patients with lung large cell neuroendocrine carcinoma
por: Xi, Junjie, et al.
Publicado: (2020)

Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades
por: Lu, Tao, et al.
Publicado: (2019)

Dissecting the single-cell transcriptome network in patients with esophageal squamous cell carcinoma receiving operative paclitaxel plus platinum chemotherapy
por: Chen, Zhencong, et al.
Publicado: (2021)

LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma
por: Chen, Zhencong, et al.
Publicado: (2022)

Prognosis of the second predominant subtype in lung adenocarcinoma: a retrospective single-center cohort study
por: Sun, Shuai, et al.
Publicado: (2022)

Multi-omics characterization and validation of invasiveness-related molecular features across multiple cancer types
por: Bi, Guoshu, et al.
Publicado: (2021)

miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways
por: Bi, Guoshu, et al.
Publicado: (2022)

A global assessment of the male predominance in esophageal adenocarcinoma
por: Xie, Shao-Hua, et al.
Publicado: (2016)

Prognostic Impact of Radiological Consolidation Tumor Ratio in Clinical Stage IA Pulmonary Ground Glass Opacities
por: Xi, Junjie, et al.
Publicado: (2021)

Benefits of surgery in the multimodality treatment of stage IIB-IIIC small cell lung cancer
por: Yang, Yong, et al.
Publicado: (2019)

A Systematic Analysis Identifies Key Regulators Involved in Cell Proliferation and Potential Drugs for the Treatment of Human Lung Adenocarcinoma
por: Wang, Kai, et al.
Publicado: (2021)

A Spindle Cell Predominant Pancreatic Solid-pseudopapillary Tumor
por: Go, Jai Hyang
Publicado: (2008)

Risk stratification model for patients with stage I invasive lung adenocarcinoma based on clinical and pathological predictors
por: Wang, Yiyang, et al.
Publicado: (2021)

Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lung
por: Kai, Yuichiro, et al.
Publicado: (2021)

Efficacy and Benefit of Postoperative Chemotherapy in Micropapillray or Solid Predominant Pattern in Stage IB Lung Adenocarcinoma: A Systematic Review and Meta-Analysis
por: Xu, Congcong, et al.
Publicado: (2021)

Palliative embolisation for intrapulmonary shunting in lepidic predominant adenocarcinoma of the lung
por: Tan, Joanne Yue-Ai, et al.
Publicado: (2015)

Transbronchial lung cryobiopsy for the diagnosis of lepidic-predominant lung adenocarcinoma
por: Pathak, Vikas, et al.
Publicado: (2019)

Prognostic Effects of Predominant Histologic Subtypes in Resected Pulmonary Adenocarcinomas
por: Yaldız, Demet, et al.
Publicado: (2019)

Pan-Driver-Negatives versus Epidermal Growth Factor Receptor Mutants for C-Stage IA Lung Adenocarcinoma with Ground-Glass Opacity
por: Li, Ming, et al.
Publicado: (2022)

Enlarged Mediastinal Lymph Nodes in Computed Tomography are a Valuable Prognostic Factor in Non-Small Cell Lung Cancer Patients with Pathologically Negative Lymph Nodes
por: Zheng, Yuansheng, et al.
Publicado: (2020)

Identification and validation of an immune cell infiltrating score predicting survival in patients with lung adenocarcinoma
por: Yang, Xiaodong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6676volnm2b8049vql7dthckl1